Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A45114 | 26034812 | Child Obes | Re: Estrada et al., "Children's Hospital Association Consensus Statements for Comorbidities of Childhood Obesity". | 2015 | Details |
| A45115 | 26034866 | Am J Surg Pathol | Ipilimumab-associated Hepatitis: Clinicopathologic Characterization in a Series of 11 Cases. | 2015 | Details |
| A45116 | 26033770 | Birth Defects Res A Clin Mol Teratol | Multicenter investigation of lifestyle-related diseases and visceral disorders in thalidomide embryopathy at around 50 years of age. | 2015 | Details |
| A45117 | 26028056 | Sleep Med | Obstructive sleep apnoea is common in adults with biopsy-proven non-alcoholic fatty liver disease. | 2015 | Details |
| A45118 | 26026745 | Gastroenterology | Tail Tale: nNOSdel1203-1434 Predicts Global Defects in Esophagogastrointestinal Transit. | 2015 | Details |
| A45119 | 26025313 | Gastroenterology | Gut Serotonin Is a Regulator of Obesity and Metabolism. | 2015 | Details |
| A45120 | 26025311 | Gastroenterology | Reply: To PMID 25479138. | 2015 | Details |
| A45121 | 26022692 | J Hepatol | Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit? | 2015 | Details |
| A45122 | 26019047 | Ann Hepatol | Insights in non-alcoholic fatty liver disease pathophysiology with lipidomic analyses. | 2015 | Details |
| A45123 | 26014325 | J Ultrasound Med | Improved method for calculating hepatic steatosis using the hepatorenal index. | 2015 | Details |
| A45124 | 26011365 | J BUON | Non-alcoholic fatty liver disease, metabolic syndrome and gastric cancer: Single center experience. | 2015 | Details |
| A45125 | 26009250 | Arch Med Res | Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis. | 2015 | Details |
| A45126 | 26004277 | Med Clin (Barc) | [Non-alcoholic fatty liver disease. Role of primary care physicians]. | 2015 | Details |
| A45127 | 25998695 | Hepatology | Intestinal farnesoid X receptor puts a fresh coat of wax on fatty liver. | 2015 | Details |
| A45128 | 25998371 | Hepatology | Pathological polyploidy in liver disease. | 2015 | Details |
| A45129 | 25993176 | Am Soc Clin Oncol Educ Book | Hepatocellular carcinoma tumor board: making sense of the technologies. | 2015 | Details |
| A45130 | 25989922 | Hepatology | Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use? | 2015 | Details |
| A45131 | 25987009 | Asian Pac J Cancer Prev | Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma. | 2015 | Details |
| A45132 | 25986821 | J Urol | Re: Non-alcoholic fatty liver disease is associated with benign prostate hyperplasia in men and with overactive bladder in women. | 2015 | Details |
| A45133 | 25986529 | Dig Dis Sci | Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B. | 2015 | Details |
| A45134 | 25974900 | Semin Liver Dis | Liver fibrosis in alcoholic liver disease. | 2015 | Details |
| A45135 | 25968152 | Aliment Pharmacol Ther | Letter: systemic therapy for psoriasis could affect the prevalence of NAFLD. | 2015 | Details |
| A45136 | 25966042 | Liver Int | Response to Serum cytokeratin-18 fragment levels predict development of type 2 diabetes mellitus in adult patients with NAFLD. | 2015 | Details |
| A45137 | 25964992 | Liver Int | Response to do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? | 2015 | Details |
| A45138 | 25959049 | Obesity (Silver Spring) | Hepatic steatosis is associated with lower levels of physical activity measured via accelerometry. | 2015 | Details |
| A45139 | 25940698 | Oncotarget | Liver polyploidy: Dr Jekyll or Mr Hide? | 2015 | Details |
| A45140 | 25939859 | Liver Int | Serum cytokeratin-18 fragment levels predict development of type 2 diabetes mellitus in adult patients with NAFLD. | 2015 | Details |
| A45141 | 25939215 | Rev Prat | [Not Available]. | 2015 | Details |
| A45142 | 25933502 | Nutrition | Vitamin E therapy on aminotransferase levels in NAFLD/NASH patients. | 2015 | Details |
| A45143 | 25933501 | Nutrition | Vitamin E therapy for NAFLD/NASH. | 2014 | Details |
| A45144 | 25923946 | Eur J Gastroenterol Hepatol | Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment. | 2015 | Details |
| A45145 | 25922396 | Clin Infect Dis | New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. | 2015 | Details |
| A45146 | 25919655 | Eur J Gastroenterol Hepatol | Is ultrasonography-diagnosed nonalcoholic fatty liver disease fibrosis score associated with the Framingham risk score? | 2015 | Details |
| A45147 | 25916279 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature. | 2015 | Details |
| A45148 | 25914250 | Hepatology | The (II)logic of iron reduction therapy for steatohepatitis. | 2015 | Details |
| A45149 | 25913160 | Liver Int | Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? | 2015 | Details |
| A45150 | 25912127 | Gastroenterol Hepatol | Is H63D a 'minor' HFE polymorphism? | 2015 | Details |
| A45156 | 25896310 | J Transl Med | Objective assessment of health or pre-chronic disease state based on a health test index derived from routinely measured clinical laboratory parameters. | 2015 | Details |
| A45157 | 25879744 | BMC Cancer | International trends in primary liver cancer incidence from 1973 to 2007. | 2015 | Details |
| A45158 | 25864227 | Ann Hepatol | Obeticholic acid: expanding the therapeutic landscape of NASH. | 2016 | Details |
| A45159 | 25863525 | J Hepatol | Exercise and improvement of NAFLD: Practical recommendations. | 2015 | Details |
| A45160 | 25862175 | Surg Obes Relat Dis | The PNPLA3 p.Ile148Met Variant and Obesity: brothers-in-arms: Comment on: PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A45161 | 25852814 | J Clin Aesthet Dermatol | Nonalcoholic Fatty liver disease and psoriasis: what a dermatologist needs to know. | 2015 | Details |
| A45162 | 25851650 | J Pediatr | The use of omega-3 Fatty acids in nonalcoholic Fatty liver disease: the end of the road or a new beginning? | 2015 | Details |
| A45163 | 25850346 | Curr Opin Gastroenterol | Aging and liver disease. | 2015 | Details |
| A45164 | 25850345 | Curr Opin Gastroenterol | Advances in hepatology: 2015. | 2015 | Details |
| A45165 | 25846391 | Aliment Pharmacol Ther | Letter: HIV-associated NAFLD--more questions than answers? Authors' reply. | 2015 | Details |
| A45166 | 25846390 | Aliment Pharmacol Ther | Letter: HIV-associated NAFLD--more questions than answers? | 2015 | Details |
| A45167 | 25845713 | Magn Reson Med | Sensitivity of chemical shift-encoded fat quantification to calibration of fat MR spectrum. | 2015 | Details |
| A45168 | 25844712 | J Pediatr Gastroenterol Nutr | Bile Acids as Biomarkers: Liver and Gut Cross Talk in NAFLD. | 2015 | Details |
| A45169 | 25843660 | Nutr Metab Cardiovasc Dis | Iron status in obesity: An independent association with metabolic parameters and effect of weight loss. | 2015 | Details |
| A45170 | 25838202 | Biochem Biophys Res Commun | Monoacylglycerol O-acyltransferase 1 is regulated by peroxisome proliferator-activated receptor γ in human hepatocytes and increases lipid accumulation. | 2015 | Details |
| A45171 | 25827821 | Expert Rev Gastroenterol Hepatol | The evolving epidemiology of hepatocellular carcinoma: a global perspective. | 2015 | Details |
| A45172 | 25820484 | Hepatology | Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients. | 2015 | Details |
| A45173 | 25817747 | Surg Obes Relat Dis | Bariatric surgery for nonalcoholic fatty liver disease in adolescents with severe obesity. | 2014 | Details |
| A45174 | 25813056 | Am J Physiol Gastrointest Liver Physiol | Kupffer cell depletion protects against the steatosis, but not the liver damage, induced by marginal-copper, high-fructose diet in male rats. | 2015 | Details |
| A45175 | 25809239 | Liver Int | Value of fetuin-A as a predictor of liver fibrosis in patients with nonalcoholic fatty liver disease. Author's reply. | 2015 | Details |
| A45176 | 25809113 | Hepatology | Is it time to advance pediatric NAFLD diagnosis to the magnetic resonance imaging era? | 2015 | Details |
| A45177 | 25805408 | Trends Endocrinol Metab | Notch signaling as a novel regulator of metabolism. | 2015 | Details |
| A45178 | 25803539 | Medicine (Baltimore) | Visceral adipose tissue area as an independent risk factor for elevated liver enzyme in nonalcoholic Fatty liver disease: erratum. | 2015 | Details |
| A45179 | 25799602 | Zhonghua Gan Zang Bing Za Zhi | [Unconditional logistic regression analysis of risk factors for nonalcoholic fatty liver disease in the Urumqi population]. | 2014 | Details |
| A45180 | 25797510 | Dtsch Arztebl Int | In reply. | 2015 | Details |
| A45181 | 25797509 | Dtsch Arztebl Int | Benefit: "therapeutic indication". | 2015 | Details |
| A45182 | 25797508 | Dtsch Arztebl Int | Mediterranean diet. | 2015 | Details |
| A45183 | 25797507 | Dtsch Arztebl Int | Difficult-to-understand point. | 2015 | Details |
| A45184 | 25788206 | Hepatol Int | Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver disease. | 2015 | Details |
| A45185 | 25782472 | Liver Int | Value of fetuin-A as a predictor of liver fibrosis in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A45186 | 25774554 | Endocrinology | Vitamin d deficiency attenuates high-fat diet-induced hyperinsulinemia and hepatic lipid accumulation in male mice. | 2015 | Details |
| A45187 | 25767868 | MMW Fortschr Med | [Interview with PD Dr. Anton Gillessen, Münster. Non-alcoholic fatty liver: change in the life style!]. | 2015 | Details |
| A45188 | 25765619 | Climacteric | Selection criteria for patients with non-alcoholic fatty liver disease and diabetes mellitus to achieve reliable results. | 2015 | Details |
| A45189 | 25765160 | Obes Facts | Association of peripheral total and differential leukocyte counts with obesity-related complications in young adults. | 2015 | Details |
| A45190 | 25763510 | JIMD Rep | Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia. | 2015 | Details |
| A45191 | 25762021 | Liver Int | Response to ELF cut-off points: aetiology is also a relevant factor. | 2015 | Details |
| A45192 | 25761756 | Hepatology | Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking. | 2015 | Details |
| A45193 | 25753820 | Hepatology | Obeticholic acid and resveratrol in nonalcoholic fatty liver disease: all that is gold does not glitter, not all those who wander are lost. | 2015 | Details |
| A45194 | 25747380 | Atherosclerosis | Fatty liver, inflamed blood and calcified coronary arteries: lessons and uncertainties from the multiethnic study of atherosclerosis -commentary on the study of Al Rifai et al. | 2015 | Details |
| A45195 | 25736142 | Aliment Pharmacol Ther | Editorial: alcohol and obesity - the double peril. | 2015 | Details |
| A45196 | 25728548 | Liver Int | ELF cut-off points: aetiology is also a relevant factor. | 2015 | Details |
| A45197 | 25726736 | Gastroenterology | Is obeticholic Acid the solution to nonalcoholic steatohepatitis? | 2015 | Details |
| A45198 | 25725187 | Acta Med Iran | Comments on: predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients. | 2015 | Details |
| A45199 | 25714573 | J Pediatr Gastroenterol Nutr | The vitamin D controversy. | 2015 | Details |
| A45200 | 25687425 | J Hepatol | The TM6SF2 rs58542926 T allele is significantly associated with non-alcoholic fatty liver disease in Chinese. | 2015 | Details |
| A45201 | 25681555 | J Hepatol | Non-alcoholic fatty liver - perhaps not so benign. | 2015 | Details |
| A45202 | 25681377 | Clin Infect Dis | Editorial Commentary: Elevated Aminotransferase Levels Among HIV-Infected Persons: What's Lurking Under the Surface? | 2015 | Details |
| A45203 | 25681160 | J Hepatol | WITHDRAWN: Loss of hepatic HIF-1α accelerates lipid accumulation by inhibiting peroxisomal fatty acid oxidation in nonalcoholic fatty liver disease. | 2015 | Details |
| A45204 | 25680670 | Gastroenterology | Association Between Psychological Distress and Liver Disease Mortality: A Meta-analysis of Individual Study Participants. | 2015 | Details |
| A45205 | 25676807 | Eur J Intern Med | Circulating homocysteine in nonalcoholic fatty liver disease. | 2015 | Details |
| A45206 | 25672052 | J Assoc Physicians India | Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). | 2014 | Details |
| A45207 | 25659210 | Aliment Pharmacol Ther | Editorial: NAFLD in HIV infection--call for action. Authors' reply. | 2015 | Details |
| A45208 | 25659209 | Aliment Pharmacol Ther | Editorial: NAFLD in HIV infection--call for action. | 2015 | Details |
| A45209 | 25654600 | Nat Med | Reducing peripheral serotonin turns up the heat in brown fat. | 2015 | Details |
| A45210 | 25647851 | Zhonghua Gan Zang Bing Za Zhi | [Current perspectives on the roles of PPARa in nonalcoholic fatty liver disease and hepatocarcinogenesis]. | 2014 | Details |
| A45211 | 25647847 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and treatment of non-alcoholic fatty liver disease]. | 2014 | Details |
| A45212 | 25647553 | Rev Fac Cien Med Univ Nac Cordoba | Overweight and Obesity in Southern Italy: their association with social and life-style characteristics and their effect on levels of biologic markers. | 2014 | Details |
| A45213 | 25645967 | Nat Rev Gastroenterol Hepatol | NAFLD. Leaky guts: intestinal permeability and NASH. | 2015 | Details |
| A45214 | 25644347 | J Nutr | Lycopene and apo-10'-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in β-carotene-9',10'-oxygenase knockout male mice. | 2014 | Details |
| A45215 | 25639710 | Gastroenterology | TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? | 2015 | Details |
| A45216 | 25635125 | J Lipid Res | The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination. | 2015 | Details |
| A45217 | 28210672 | Cell Mol Gastroenterol Hepatol | The Gut Microbiota, Intestinal Permeability, Bacterial Translocation, and Nonalcoholic Fatty Liver Disease: What Comes First? | 2015 | Details |
| A45218 | 25631653 | Aliment Pharmacol Ther | Editorial: Call to screen for NAFLD and NASH in psoriasis. | 2015 | Details |